Liste d'obligations internationales ( Toutes )

EmetteurPays
Coupon minCoupon maxTranche minimale <= Devise
Prix minPrix maxEcheance minEcheance max
Exclure échuesExclure en défaut



Société émettrice Code ISIN Devise Coupon Montant minimal Maturité Prix sur le marché
AbbVie Inc. US00287YBD04 prospectus USD 4.875% 2 000 USD 13/11/2048 88.0795
AbbVie Inc. XS1520907814 prospectus EUR 2.125% 100 000 EUR 17/11/2028 100
AbbVie Inc. US00287YAG44 prospectus USD 1.2%   06/11/2015 Echue
AbbVie Inc. USU0029QAV87 prospectus USD 3.2% 2 000 USD 21/11/2029 90.471
AbbVie Inc. USU0029QAN61 prospectus USD 2.3% 2 000 USD 21/11/2022 Echue
AbbVie Inc. USU0029QAQ92 prospectus USD 2.6% 2 000 USD 21/11/2024 Echue
AbbVie Inc. US00287YAU38 prospectus USD 2.3% 2 000 USD 13/05/2021 Echue
AbbVie Inc. US00287YAQ26 prospectus USD 3.6% 2 000 USD 13/05/2025 Echue
AbbVie Inc. US00287YAR09 prospectus USD 4.5% 2 000 USD 13/05/2035 100
AbbVie Inc. US00287YAS81 prospectus USD 4.7% 2 000 USD 14/05/2045 100
AbbVie Inc. US00287YAP43 prospectus USD 3.2% 2 000 USD 05/11/2022 Echue
AbbVie Inc. US00287YAL39 prospectus USD 2.9% 2 000 USD 05/11/2022 Echue
AbbVie Inc. US00287YAX76 prospectus USD 2.85% 2 000 USD 13/05/2023 Echue
AbbVie Inc. US00287YBC21 prospectus USD 3.75% 2 000 USD 13/11/2023 Echue
AbbVie Inc. US00287YAV11 prospectus USD 4.3% 2 000 USD 13/05/2036 100
AbbVie Inc. US00287YBE86 prospectus USD 3.375% 2 000 USD 13/11/2021 Echue
AbbVie Inc. US00287YBF51 prospectus USD 4.25% 2 000 USD 13/11/2028 100.074
AbbVie Inc. XS2055646918 EUR 0.75% 100 000 EUR 17/11/2027 100
AbbVie Inc. USU0029QAL06 prospectus USD 2.15% 2 000 USD 18/11/2021 Echue
AbbVie Inc. USU0029QAP10 prospectus USD 2.346% 2 000 USD 20/11/2022 Echue
AbbVie Inc. USU0029QAM88 prospectus USD 2.153% 2 000 USD 18/11/2021 Echue
AbbVie Inc. USU0029QAU05 prospectus USD 2.95% 2 000 USD 20/11/2026 100
AbbVie Inc. USU0029QAR75 prospectus USD 4.05% 2 000 USD 20/11/2039 Echue
AbbVie Inc. USU0029QAT32 prospectus USD 2.046% 2 000 USD 20/05/2021 Echue
AbbVie Inc. USU0029QAS58 prospectus USD 4.25% 2 000 USD 20/11/2049 100
AbbVie Inc. US00287YAT64 prospectus USD 2.5% 2 000 USD 14/05/2020 Echue
AbbVie Inc. US00287YAN94 prospectus USD 1.8% 2 000 USD 14/05/2018 Echue
AbbVie Inc. USU0029QBC97 prospectus USD 3.85% 2 000 USD 14/06/2024 Echue
AbbVie Inc. USU0029QAY27 prospectus USD 5% 2 000 USD 14/12/2021 Echue
AbbVie Inc. USU0029QAZ91 prospectus USD 3.45% 2 000 USD 15/03/2022 Echue
AbbVie Inc. USU0029QBA32 prospectus USD 3.25% 2 000 USD 01/10/2022 Echue
AbbVie Inc. USU0029QBB15 prospectus USD 2.8% 2 000 USD 14/03/2023 Echue
AbbVie Inc. US00287YBR99 prospectus USD 4.05% 2 000 USD 20/11/2039 100
AbbVie Inc. US00287YBQ17 prospectus USD 2.6% 2 000 USD 20/11/2024 Echue
AbbVie Inc. US00287YBT55 prospectus USD 0.597% 2 000 USD 20/05/2021 Echue
AbbVie Inc. US00287YBS72 prospectus USD 4.25% 2 000 USD 20/11/2049 68.189
AbbVie Inc. US00287YBN85 prospectus USD 0.897% 2 000 USD 20/11/2022 Echue
AbbVie Inc. US00287YBW84 prospectus USD 3.2% 2 000 USD 20/11/2029 91.466
AbbVie Inc. US00287YBL20 prospectus USD 2.3% 2 000 USD 20/11/2022 Echue
AbbVie Inc. US00287YBJ73 prospectus USD 0.691% 2 000 USD 18/11/2021 Echue
AbbVie Inc. US00287YBG35 prospectus USD 2.15% 2 000 USD 18/11/2021 Echue
AbbVie Inc. US00287YAA73 USD 1.2% 2 000 USD 06/11/2015 Echue
AbbVie Inc. US00287YDC03 USD 3.8% 2 000 USD 15/03/2025 Echue
AbbVie Inc. US00287YBX67 USD 3.2% 2 000 USD 20/11/2029 96.379
AbbVie Inc. US00287YCB39 USD 4.25% 2 000 USD 20/11/2049 83.6288
AbbVie Inc. US00287YBV02 USD 2.95% 2 000 USD 20/11/2026 100
AbbVie Inc. US00287YCZ07 USD 4.625% 2 000 USD 30/09/2042 87.836
AbbVie Inc. US00287YCS63 USD 3.45% 2 000 USD 14/03/2022 Echue
AbbVie Inc. US00287YDB20 USD 4.75% 2 000 USD 14/03/2045 100
AbbVie Inc. US00287YCT47 USD 3.25% 2 000 USD 30/09/2022 Echue
AbbVie Inc. US00287YCU10 USD 2.8% 2 000 USD 14/03/2023 Echue
AbbVie Inc. US00287YCR80 USD 5% 2 000 USD 14/12/2021 Echue
AbbVie Inc. US00287YBM03 USD 2.3% 2 000 USD 20/11/2022 Echue
AbbVie Inc. US00287YBK47 USD 0.691% 2 000 USD 21/09/2050 Echue
AbbVie Inc. XS1520897163 prospectus EUR 0.375% 100 000 EUR 18/11/2019 Echue
AbbVie Inc. XS1520899532 prospectus EUR 1.375% 100 000 EUR 17/05/2024 Echue
AbbVie Inc. US00287YCY32 USD 4.55% 2 000 USD 15/03/2035 96.8232
AbbVie Inc. USU0029QAD89 USD 4.4% 2 000 USD 06/11/2042 100
AbbVie Inc. XS2117754833 EUR 1.25% 100 000 EUR 31/05/2024 Echue
AbbVie Inc. XS2117753603 EUR 0% 100 000 EUR 15/11/2020 Echue
AbbVie Inc. US00287YAF60 USD 2%   05/11/2018 Echue
AbbVie Inc. XS2125914593 EUR 1.25% 100 000 EUR 31/05/2024 Echue
AbbVie Inc. USU0029QAX44 USD 4.875% 2 000 USD 15/02/2021 Echue
AbbVie Inc. US00287YBY41 USD 0% 2 000 USD 21/05/2021 Echue
AbbVie Inc. US00287YAK55 prospectus USD 2% 1 000 USD 06/11/2018 Echue
AbbVie Inc. XS2125913603 EUR 0.5% 100 000 EUR 01/06/2021 Echue
AbbVie Inc. US00287YBH18 USD 2.15% 2 000 USD 19/11/2021 Echue
AbbVie Inc. USU0029QAA41 USD 1.2% 2 000 USD 06/11/2015 Echue
AbbVie Inc. US00287YAH27 prospectus USD 0% 2 000 USD 06/11/2015 Echue
AbbVie Inc. US00287YAJ82 prospectus USD 1.75% 2 000 USD 06/11/2017 Echue
AbbVie Inc. XS2117754163 EUR 0.5% 100 000 EUR 01/06/2021 Echue
AbbVie Inc. USU0029QAB24 USD 1.75% 2 000 USD 06/11/2017 Echue
AbbVie Inc. USU0029QBE53 USD 4.625% 2 000 USD 01/10/2042 Echue
AbbVie Inc. XS2117754593 EUR 1.5% 100 000 EUR 14/11/2023 Echue
AbbVie Inc. USU0029QBG02 USD 4.75% 2 000 USD 15/03/2045 126.763
AbbVie Inc. US00287YBP34 USD 0% 2 000 USD 21/11/2022 Echue
AbbVie Inc. US00287YBZ16 USD 2.6% 2 000 USD 21/11/2024 Echue
AbbVie Inc. US00287YCX58 USD 3.8% 2 000 USD 15/03/2025 Echue
AbbVie Inc. USU0029QBD70 USD 4.55% 2 000 USD 15/03/2035 123.737
AbbVie Inc. XS2117755053 EUR 2.625% 100 000 EUR 15/11/2028 100
AbbVie Inc. XS2117755566 EUR 2.125% 100 000 EUR 01/06/2029 100
AbbVie Inc. XS2125913942 EUR 1.5% 100 000 EUR 15/11/2023 Echue
AbbVie Inc. XS2125914833 EUR 2.625% 100 000 EUR 15/11/2028 100
AbbVie Inc. US00287YDA47 USD 4.85% 2 000 USD 15/06/2044 100
AbbVie Inc. USU0029QBF29 USD 4.85% 2 000 USD 15/06/2044 128.708
AbbVie Inc. US00287YCG26 USD 3.25% 2 000 USD 01/10/2022 Echue
AbbVie Inc. US00287YAC30 USD 2.9% 2 000 USD 05/11/2022 Echue
AbbVie Inc. US00287YCH09 USD 2.8% 2 000 USD 14/03/2023 Echue
AbbVie Inc. US00287YCV92 USD 3.85% 2 000 USD 15/06/2024 Echue
AbbVie Inc. US00287YBU29 prospectus USD 2.95% 2 000 USD 20/11/2026 99.322
AbbVie Inc. XS2055647213 EUR 1.25%   17/11/2031 89.51
AbbVie Inc. XS2125914916 EUR 2.125%   31/05/2029 97.26
AbbVie Inc. USU0029QAC07 USD 2.9%   06/11/2022 Echue
AbbVie Inc. US00287YCA55 USD 4.05% 2 000 USD 20/11/2039 85.01
AbbVie Inc. US00287YAW93 prospectus USD 4.45%   13/05/2046 84.199
AbbVie Inc. US00287YDT38 USD 4.95% 2 000 USD 15/03/2031 102.881
AbbVie Inc. US00287YDW66 USD 5.4% 2 000 USD 15/03/2054 96.671
AbbVie Inc. US00287YDV83 USD 5.35% 2 000 USD 15/03/2044 96.773
AbbVie Inc. US00287YAY59 prospectus USD 3.2%   13/05/2026 Echue
AbbVie Inc. XS2117754916 EUR 1.25% 100 000 EUR 01/06/2024 Echue
AbbVie Inc. US00287YDX40 USD 5.5%   15/03/2064 95.826
AbbVie Inc. US00287YDU01 USD 5.05%   15/03/2034 102.626
AbbVie Inc. US00287YEA38 USD 5.2%   15/03/2035 102.567
AbbVie Inc. US00287YDR71 USD 4.8%   15/03/2027 100.598
AbbVie Inc. US00287YEB11 USD 5.6%   15/03/2055 99.527
AbbVie Inc. US00287YDZ97 USD 4.875%   14/03/2030 101.99
AbbVie Inc. US00287YDS54 USD 4.8%   15/03/2029 101.25
AbbVie Inc. US00287YDY23 USD 4.65%   15/03/2028 100.99
AbbVie Inc. US00287YEG08 USD 4.75%   14/03/2036 98.82
AbbVie Inc. US00287YAM12 prospectus USD 4.4%   05/11/2042 84.45
AbbVie Inc. US00287YEE59 USD 4.125%   15/03/2031 100
AbbVie Inc. US00287YEH80 USD 5.55% 2 000 USD 15/03/2056 92.823
AbbVie Inc. US00287YEJ47 USD 5.65% 2 000 USD 15/03/2066 100
AbbVie Inc. US00287YEF25 USD 4.4% 2 000 USD 15/03/2033 96.131

AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology.

AbbVie est une société biopharmaceutique mondiale développant et commercialisant des médicaments innovants dans les domaines de l'immunologie, de l'oncologie, des maladies neurologiques et des soins spécialisés.

AbbVie è una società biofarmaceutica globale che si concentra sullo sviluppo e la commercializzazione di farmaci innovativi in aree terapeutiche quali l'immunologia, l'oncologia, le malattie neurologiche e le malattie infettive.